Legal and ethical considerations Flashcards
agencies regulating and enforcing safety of medications
health canada
RCMP
individual provincial and territorial laws
CRNA and CNO created laws that allowed nurses to prescribe medications amd order diagnostic tests in AB who work in?
specialty areas
Canadian drug legislation began in?
1875
The federal regulator responsible for administration and enforcement of the food and drugs act and food and drugs regulations, and the controlled drug and substance act?
The health products and food branch inspectorate (HPFB) of Health Canada
The two acts that from the underlying foundation for drug laws in Canada?
food and drugs act
controlled drug and substance act
Canadian federal authority that regulates these acts?
the therapeutic products directorate (TPD)
TPD- ensure drug effectiveness and protect patients
food and drugs act
controlled drug and substance act
designed to protect the consumer from potential health hazards and fraud or deception in the sale of foods, drugs, cosmetics, and medical devices
a federal law governing the collection, use, and disclosure of personal information
require all health care providers, insurance, employers … to maintain patient privacy
such as medications, account numbers, prescription…
the personal protection and electronic documents act (PIPEDA)
federal legislation is to ensure
safety and efficacy of new drugs and protect patient confidentiality
Food and Drugs Act
governs food, drugs, cosmetics, and medical devices in Canada
The legend, Canadian standard drug or CSD
must appear on the inner and outer labels of the drug packaging to show that a drug meets the standards for which it is prescribed
Drug samples
are regulated
with exception of the distribution under prescribed conditions to physicians, dentists and pharmacists.
Pr symbol
prescription drug
Food and drug act also regulates
the information manufacturers may put on the drug label, including directions for use
Food and drug regulations
current, consolidated regulations of the food and drugs act
controlled drugs are dispensed only by
prescription
a controlled drug must be marked with the symbol
C, in a clear manner and in as conspicuous color and size in the upper left quarter of the label
controlled drugs and substances act (CDSA)
passed in 1997
provides the requirements for the control and sale of narcotics, controlled drugs, and substances of misuse
controlled substances
medical treatment legally obtained only with prescription from a licensed HCP
This symbol is printed on the label of controlled drugs
N
most dangerous drugs
Schedule 1
opiates- (opium, heroin, morphine, cocaine)
fentanyl
methampetamine
Schedule 2
synthetic cannabinoid receptor 1 agonists
all other cannabis drug are now regulated under
cannabis regulations and cannabis act
schedule 3
more dangerous drugs
amphetamines
lysergic acids diethyl amide (LSD)
schedule 4
dangerous but have therapuetic uses:
barbituates
anabolic steroids
prescription needed
schedule 5 and 6
contain precursors required to produce controlled substances
schedule 8 and 8
contain amounts of cannabis and cannabis resin required for charge and sentencing purposes
the RCMP is responsible for enforcing the
CDSA and related sections of crimminal code, and exempts police forces from sections of CDSA for the pupose of performing their duties
The benzodiazepines and other targeted substances
restrictions in regard to benzodiazepines, their salts and derivatives
the precursor control regulations
control for essential and precursor chemicals routinely used in clandestine labs for the production of methamphetamine, ecstacy, and other schedule 3 drugs
The cannabis act and cannabis regulations
address cannabis for medical purposes
prescription
access to cannabis
buying direct from a seller licensed by the govt, register eith health canada to produce prescribed amount of cannabis, assigning a designate to produce the product on their behalf
Natural health products regulations
cover natural health products such as vitamins/ minerals, herbal, traditional medicines…
probiotic, amino acid, essential fatty acids
The therapeutic products directorate
approves drugs for clinical safety and efficacy before they are brought to the market
priority review of drug submissions process
or fast track approval
eligible submission- target of 180 days compared to 300 days (for non-priority)
AIDS- public health crisis where TPD granted expedited drug approval
drug approval process
complex and prolonged
begins with preclinical testing phase (invitro studies and animal studies)
clinical (human) studies follow the preclinical phase
the drug is put to the market after phase 3 is completed if an investigational new drug application
submitted by the manufacturer is approved by TPD
notice of compliance
issued when health Canada decides that the drug and the manufacturing process are safe and effective, allowing manufacturers to sell the product by prescription
once a drug is approved for sale, it is assigned a computed generated
drug identification number (DIN)
In vitro
test the response of human/ mamalian cells and tissues to drugs
dead/ living subjects- surgical/ autopsy specimens
determine early if a substance is too toxic for humans
informed consent
careful explanation to the human test patient or research subject of the purpose of the study, procedures, benefits, risks
followed by a written documentaion/ consent form
voluntary
obtained before they can be enrolled in investigational new drug (IND)
Phase I
involve small numbers of healthy subject (fewer than 100)
(EXCEPT a study involving a toxic drug intended to treat- subjects will have illness where other options are not available)
determine potential adverse effects, optimal dosage range, pharmacokinetics, determine if further testing is required
blood test, UA, VS, specific monitoring
few days to few weeks
Phase II
involve larger number of volunteers (100-300)
have disease that drug is designed to diagnose or treat
closely monitored for effectiveness and adverse effects
therapuetic dosage range refined
if no adverse effect occur- can proceed to phase III
phase III
establish drugs effectiveness, safety, and dosage range
1000 to 3000 participants
followed by medical research centres and other health facilities
may be treated at the centre or spread out
purpose of large sample size is to provide info about infrequent or rare adverse effects
to enhance objectivity- a placebo is incorporated (given to a portion of subjects) to separete real benefits from apparent benefits arising out from a researcher/ subject bias regaridng expected or desired results
after phase III- company can submit new drug submission
placebo-controlled study
incorporate a placebo
blinded investigational drug study
if subject does not know whether the drug is a placebo or the original drub
but the investigator know
double blind
neither the staff nor the subject know
after the completion of study , the code on medication container is revelead in order to know who received the placebo
Canadian Patent Act
20 years after discovery of molecules
and includes the 10 to 12 year period generally required to complete drug research